Study summary

The primary objective is to compare fidaxomicin versus vancomycin for the sustained clinical cure of Clostridium difficile Infection (CDI) in adult patients receiving immunosuppressive therapy.

Additional Study Details

Phase
4
Product
N/A
Product
Fidaxomicin
Vancomycin
Placebo
Type
Interventional
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
12
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A post-marketing, blinded study to investigate how effective fidaxomicin is compared to vancomycin in the sustained cure of Clostridium Difficile Infection in adults that are receiving therapy to suppress the immune system? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Withdrawn
    LKH Graz, Univ.
    Graz, Austria, 8036
    Withdrawn
    Policlinico di Modena
    Modena, Italy, 41100
    Terminated
    Charité
    Berlin, Germany, 10117
    Withdrawn
    Instytut Hematologii i Transfu
    Warszawa, Poland, 02-776
    Terminated
    Laiko General Hospital
    Athens, Greece, 11527
    Withdrawn
    Swietokrzyskie Oncology Center
    Kielce, Poland, 25-734
    Withdrawn
    Centre of Heart Blood and Endo
    Saint Petersburg, Russian Federation, 197341
    Terminated
    Szpital Specjalistyczny w Brzo
    Brzozów, Poland, 36-200
    Withdrawn
    Institut Jules Bordet
    Brussels, Belgium, 1000
    Terminated
    General Hospital of Athens
    Athens, Greece, 10675
    Withdrawn
    St. Petersburg City Hospital #31
    Saint Petersburg, Russian Federation, 197110
    Terminated
    University Hospital of Crete
    Heraklion, Greece, 70013
    Withdrawn
    AKH Universitätsklinik
    Vienna, Austria, 1090
    Withdrawn
    IRCCS Policlinico San Matteo
    Pavia, Italy, 27100
    Withdrawn
    Medical University
    Innsbruck, Austria, 6020
    Terminated
    Univ. Klinik für Innere Medizi
    Salzburg, Austria, 5020
    Withdrawn
    HUCH
    Helsinki, Finland, 00029
    Terminated
    Institut Curie
    Paris, France, 75005
    Withdrawn
    Institut Gustave Roussy
    Villejuif, France, 94805
    Withdrawn
    MH Honvédkórház - I.Belgyógyás
    Budapest, Hungary, 1134
    Withdrawn
    Bristol Haematology and Oncology
    Bristol, United Kingdom, BS2 8ED
    Withdrawn
    R.M.Gorbacheva Inst of children
    Saint Petersburg, Russian Federation, 197022
    Withdrawn
    Szegedi Tudományegyetem Ált
    Szeged, Hungary, 6720
    Withdrawn
    Uppsala University Hospital
    Uppsala, Sweden, 75185
    Terminated
    Universitätsklinikum Halle
    Halle, Germany, 6097
    Terminated
    Universitätsklinikum
    Essen, Germany, 45417
    Withdrawn
    Karolinska University Hospital
    Huddinge, Sweden, 14186
    Terminated
    Metaxa Anticancer Hospital
    Piraeus, Greece, 18537
    Withdrawn
    Centro di Riferimento
    Aviano, Italy, 33081
    Withdrawn
    Hôpital Universitaire Erasme
    Brussels, Belgium, 1070
    Withdrawn
    Hopital Saint Louis
    Paris, France, 75475
    Withdrawn
    Main Military Clinical Hospital
    Moscow, Russian Federation, 105229
    Withdrawn
    H. U. Politecnico La Fe
    Valencia, Spain, 46026
    Terminated
    Klinik I für Innere Medizin
    Koln, Germany, 50937
    Terminated
    Hôpital Necker
    Paris, France, 75743
    Withdrawn
    Clinics of Samara State Medical
    Samara, Russian Federation, 443079
    Withdrawn
    Hematology Research Center
    Moscow, Russian Federation, 125167
    Withdrawn
    CHU de Liege
    Liege, Belgium, 4000
    Terminated
    H.U. Gregorio Maranon
    Madrid, Spain, 28007
    Withdrawn
    Policlinico S.Orsola-Malpighi
    Bologna, Italy, 40138
    Terminated
    Herlev University Hospital
    Herlev, Denmark, 2730
    Terminated
    Hospital 12 de Octubre
    Madrid, Spain, 28041
    Withdrawn
    Azienda Ospedaliera Pisana
    Pisa, Italy, 56124
    Terminated
    H. U. de Bellvitge
    Barcelona, Spain, 08907
    Withdrawn
    Imperial College School of Med
    London, United Kingdom, W12 0HS
    Withdrawn
    Diparitmento di Malattie
    Genova, Italy, 16132
    Withdrawn
    Semmelweis Egyetem Kútvölgyi
    Budapest, Hungary, 1125
    Withdrawn
    Turku Hospital
    Turku, Finland, 20251
    Withdrawn
    Szent István és Szent László
    Budapest, Hungary, 1097

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?